Literature DB >> 23431171

MOZ increases p53 acetylation and premature senescence through its complex formation with PML.

Susumu Rokudai1, Oleg Laptenko, Suzzette M Arnal, Yoichi Taya, Issay Kitabayashi, Carol Prives.   

Abstract

Monocytic leukemia zinc finger (MOZ)/KAT6A is a MOZ, Ybf2/Sas3, Sas2, Tip60 (MYST)-type histone acetyltransferase that functions as a coactivator for acute myeloid leukemia 1 protein (AML1)- and Ets family transcription factor PU.1-dependent transcription. We previously reported that MOZ directly interacts with p53 and is essential for p53-dependent selective regulation of p21 expression. We show here that MOZ is an acetyltransferase of p53 at K120 and K382 and colocalizes with p53 in promyelocytic leukemia (PML) nuclear bodies following cellular stress. The MOZ-PML-p53 interaction enhances MOZ-mediated acetylation of p53, and this ternary complex enhances p53-dependent p21 expression. Moreover, we identified an Akt/protein kinase B recognition sequence in the PML-binding domain of MOZ protein. Akt-mediated phosphorylation of MOZ at T369 has a negative effect on complex formation between PML and MOZ. As a result of PML-mediated suppression of Akt, the increased PML-MOZ interaction enhances p21 expression and induces p53-dependent premature senescence upon forced PML expression. Our research demonstrates that MOZ controls p53 acetylation and transcriptional activity via association with PML.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23431171      PMCID: PMC3593914          DOI: 10.1073/pnas.1300490110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  Involvement of FKHR-dependent TRADD expression in chemotherapeutic drug-induced apoptosis.

Authors:  Susumu Rokudai; Naoya Fujita; Osamu Kitahara; Yusuke Nakamura; Takashi Tsuruo
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

2.  A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia.

Authors:  M Carapeti; R C Aguiar; J M Goldman; N C Cross
Journal:  Blood       Date:  1998-05-01       Impact factor: 22.113

3.  The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein.

Authors:  M Alcalay; L Tomassoni; E Colombo; S Stoldt; F Grignani; M Fagioli; L Szekely; K Helin; P G Pelicci
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

4.  Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain.

Authors:  W Gu; R G Roeder
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

Review 5.  The p53 and Mdm2 families in cancer.

Authors:  Dan Michael; Moshe Oren
Journal:  Curr Opin Genet Dev       Date:  2002-02       Impact factor: 5.578

6.  Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase-1 and p70 S6 kinase.

Authors:  D R Alessi; F B Caudwell; M Andjelkovic; B A Hemmings; P Cohen
Journal:  FEBS Lett       Date:  1996-12-16       Impact factor: 4.124

7.  Acetylation of lysine 120 of p53 endows DNA-binding specificity at effective physiological salt concentration.

Authors:  Eyal Arbely; Eviatar Natan; Tobias Brandt; Mark D Allen; Dmitry B Veprintsev; Carol V Robinson; Jason W Chin; Andreas C Joerger; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-27       Impact factor: 11.205

8.  The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR.

Authors:  H de Thé; C Lavau; A Marchio; C Chomienne; L Degos; A Dejean
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

9.  Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation properties.

Authors:  P P Pandolfi; F Grignani; M Alcalay; A Mencarelli; A Biondi; F LoCoco; F Grignani; P G Pelicci
Journal:  Oncogene       Date:  1991-07       Impact factor: 9.867

10.  The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein.

Authors:  J Borrow; V P Stanton; J M Andresen; R Becher; F G Behm; R S Chaganti; C I Civin; C Disteche; I Dubé; A M Frischauf; D Horsman; F Mitelman; S Volinia; A E Watmore; D E Housman
Journal:  Nat Genet       Date:  1996-09       Impact factor: 38.330

View more
  67 in total

1.  STXBP4 Drives Tumor Growth and Is Associated with Poor Prognosis through PDGF Receptor Signaling in Lung Squamous Cell Carcinoma.

Authors:  Yukihiro Otaka; Susumu Rokudai; Kyoichi Kaira; Michiru Fujieda; Ikuko Horikoshi; Reika Iwakawa-Kawabata; Shinji Yoshiyama; Takehiko Yokobori; Yoichi Ohtaki; Kimihiro Shimizu; Tetsunari Oyama; Jun'ichi Tamura; Carol Prives; Masahiko Nishiyama
Journal:  Clin Cancer Res       Date:  2017-01-13       Impact factor: 12.531

2.  De novo nonsense mutations in KAT6A, a lysine acetyl-transferase gene, cause a syndrome including microcephaly and global developmental delay.

Authors:  Valerie A Arboleda; Hane Lee; Naghmeh Dorrani; Neda Zadeh; Mary Willis; Colleen Forsyth Macmurdo; Melanie A Manning; Andrea Kwan; Louanne Hudgins; Florian Barthelemy; M Carrie Miceli; Fabiola Quintero-Rivera; Sibel Kantarci; Samuel P Strom; Joshua L Deignan; Wayne W Grody; Eric Vilain; Stanley F Nelson
Journal:  Am J Hum Genet       Date:  2015-02-26       Impact factor: 11.025

3.  STXBP4 regulates APC/C-mediated p63 turnover and drives squamous cell carcinogenesis.

Authors:  Susumu Rokudai; Yingchun Li; Yukihiro Otaka; Michiru Fujieda; David M Owens; Angela M Christiano; Masahiko Nishiyama; Carol Prives
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-07       Impact factor: 11.205

4.  P53 mutations and cancer: a tight linkage.

Authors:  Francesco Perri; Salvatore Pisconti; Giuseppina Della Vittoria Scarpati
Journal:  Ann Transl Med       Date:  2016-12

Review 5.  Crosstalk between epigenetic readers regulates the MOZ/MORF HAT complexes.

Authors:  Brianna J Klein; Marie-Eve Lalonde; Jacques Côté; Xiang-Jiao Yang; Tatiana G Kutateladze
Journal:  Epigenetics       Date:  2013-10-29       Impact factor: 4.528

Review 6.  PML nuclear bodies: assembly and oxidative stress-sensitive sumoylation.

Authors:  Umut Sahin; Hugues de Thé; Valérie Lallemand-Breitenbach
Journal:  Nucleus       Date:  2014       Impact factor: 4.197

7.  Impact of the adenoviral E4 Orf3 protein on the activity and posttranslational modification of p53.

Authors:  Caroline J DeHart; David H Perlman; S J Flint
Journal:  J Virol       Date:  2015-01-07       Impact factor: 5.103

Review 8.  Signaling coupled epigenomic regulation of gene expression.

Authors:  R Kumar; S Deivendran; T R Santhoshkumar; M R Pillai
Journal:  Oncogene       Date:  2017-06-26       Impact factor: 9.867

Review 9.  The emerging role of PI3K/AKT-mediated epigenetic regulation in cancer.

Authors:  Jennifer M Spangle; Thomas M Roberts; Jean J Zhao
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-03-14       Impact factor: 10.680

10.  PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence.

Authors:  Lisa Ivanschitz; Yuki Takahashi; Florence Jollivet; Olivier Ayrault; Morgane Le Bras; Hugues de Thé
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.